277
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH LETTER

Course of glycaemia in poorly controlled type 2 diabetes patients 2.5 years after optimizing oral treatment in general practice

, &
Pages 80-82 | Received 14 Jan 2005, Published online: 11 Jul 2009

References

  • Berghout LM, Gorter KJ, Rutten GEHM. Improvement of glycaemic control without exogenous insulin in 40% of poorly regulated patients with type 2 diabetes mellitus; a study in 18 Dutch general practices. Ned Tijdschr Geneeskd 2001;145:2035–9 (abstract in English).
  • Goudswaard AN, Stolk RP, Valk HW de, Rutten GEHM. Improving glycaemic control in patients with type 2 diabetes mellitus without insulin. Diabet Med 2003; 20: 540–4
  • Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005–12
  • Goudswaard AN, Stolk RP, Zuithoff NPA, Valk HW de, Rutten GEHM. Starting insulin therapy in patients with type 2 diabetes: with or without continuation of oral hypoglycaemic agents? A randomized trial in primary care. J Fam Pract 2004; 53: 393–9
  • Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes. JAMA 1997; 278: 1663–700
  • Dunn NR, Bough P. Standards of care of diabetic patients in a typical English community. Br J Gen Pract 1996; 46: 401–5
  • Wiersma TJ, Heine RJ, Rutten GEHM. [Summary of the practice guideline “Diabetes mellitus type 2” (first revision) of the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 1999; 143: 1688–91
  • Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet 2002; 359: 341–5
  • Cefalu WT. Evaluation of alternative strategies for optimizing glycemia: progress to date. Am J Med 2002; 113: 23S–35S
  • UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.